KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Receivables (2016 - 2025)

Humana (HUM) has disclosed Receivables for 16 consecutive years, with $3.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Receivables changed N/A to $3.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 billion, a N/A change, with the full-year FY2025 number at $3.4 billion, changed N/A from a year prior.
  • Receivables was $3.4 billion for Q4 2025 at Humana, up from $2.7 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $4.5 billion in Q2 2025 to a low of $1.4 billion in Q2 2023.
  • A 4-year average of $2.7 billion and a median of $2.4 billion in 2021 define the central range for Receivables.
  • Peak YoY movement for Receivables: skyrocketed 65.55% in 2021, then tumbled 57.58% in 2023.
  • Humana's Receivables stood at $2.0 billion in 2021, then decreased by 7.34% to $1.9 billion in 2022, then fell by 1.67% to $1.8 billion in 2023, then surged by 87.99% to $3.4 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Receivables are $3.4 billion (Q4 2025), $2.7 billion (Q3 2025), and $4.5 billion (Q2 2025).